9995.HK Current Ratio

The Current Ratio of RemeGen Co Ltd (9995.HK) is 3.73.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

9995.HK Current Ratio - Historical Value

Date	Value
2020-12-31	3.73
2019-12-31	0.16
2018-12-31	0.07

9995.HK Current Ratio - Peers Comparison

Ticker	Name	Value
2181.HK	Mabpharm Ltd	1.17
300149.SZ	ChemPartner PharmaTech Co Ltd	1.70
688266.SS	Suzhou Zelgen Biopharmaceuticals Co Ltd	2.22
1875.HK	TOT BIOPHARM International Co Ltd	1.81
300832.SZ	Shenzhen New Industries Biomedical Engineering Co Ltd	8.56
688180.SS	Shanghai Junshi Biosciences Co Ltd	1.72
4587.T	PeptiDream Inc	3.11
6855.HK	Ascentage Pharma Group International	1.26
6998.HK	Genor Biopharma Holdings Ltd	8.74
9939.HK	Kintor Pharmaceutical Ltd	4.74
688363.SS	Bloomage Biotechnology Corp Ltd	2.04
000403.SZ	Pacific Shuanglin Bio-pharmacy Co Ltd	3.72
002252.SZ	Shanghai RAAS Blood Products Co Ltd	5.60
1167.HK	Jacobio Pharmaceuticals Group Co Ltd	4.89
2126.HK	JW (Cayman) Therapeutics Co Ltd	4.78
603087.SS	Gan & Lee Pharmaceuticals	7.98
688177.SS	Bio-Thera Solutions Ltd	0.81
6978.HK	Immunotech Biopharm Ltd	0.20
300676.SZ	BGI Genomics Co Ltd	2.41
688520.SS	Sinocelltech Group Ltd	0.52
9926.HK	Akeso Inc	5.15
9969.HK	InnoCare Pharma Ltd	19.49
000504.SZ	Landfar Bio medicine Co Ltd	1.45
002007.SZ	Hualan Biological Engineering Inc	4.07
300142.SZ	Walvax Biotechnology Co Ltd	2.98
300653.SZ	Yantai Zhenghai Bio-Tech Co Ltd	8.56
600161.SS	Beijing Tiantan Biological Products Corp Ltd	6.89
9966.HK	Alphamab Oncology	5.84